Team: Radhika Mardikar, Preethi Bhat, Vikki Qian, Sonya Wong, Tim Li

Client: Dr. Steven Hetts, Chief of Interventional Neuroradiology at the UCSF Mission Bay Hospitals

“Our project investigated the application of the ChemoFilter within unresectable hepatic tumors. To mitigate patient toxicity during chemotherapeutic treatment of patients with hepatocellular carcinomas (HCC), the ChemoFilter acts to filter out filtering out excess chemotherapeutic before it reaches other organ systems, while allowing continued blood flow through the target vessels. However, while the device is effective at capturing the drug, it was fixed in size and was not modular for all potential vein sizes.

​Our top user need is to ensure that the device size is adjustable to fit in a variety of hepatic vein diameters in patients with non-resectable liver cancer in order to decrease overall negative systemic toxicity and ultimately increase treatment success rates.”